The angiogenic and fibrogenic activities of fibrin sealant (Tisseel) s
uggest that it could enhance osteoinductivity during the first days af
ter implantation. To test this hypothesis, the osteoinductivity of sea
led and unsealed bone matrix gelatin was tested by implantation into r
at abdominal wall muscle pouches for two to ten days. A sponge of coll
agen with or without fibrin sealant was used for control. Alkaline pho
sphatase (ALPase) was employed to quantify osteoinduction, and myelope
roxidase (MPO) was used to determine the inflammatory reaction. Plain
histologic analysis of bone matrix gelatin implants at Days 2, 4, and
10 did not demonstrate any significant differences between sealed and
nonsealed implants. Histologic analysis at Day 21 confirmed the osteoi
nductivity of the implant. The combination of bone matrix gelatin and
fibrin sealant induced an early significant increase in ALPase activit
y, which could be interpreted as early induction of histologically und
etectable osteogenesis. A simultaneous increase in the level of MPO su
ggested that the bone matrix gelatin/fibrin sealant-induced ALPase rea
ction might be caused by an inflammatory process, but neutrophil count
ing did not correlate to the MPO data. Morphometry, however, seems to
be insufficient to assay a heterogenous histologic distribution of sin
gular cells. It is proposed that the ALP/MPO ratio may be used as an i
nflammation-independent marker of osteogenesis. This study does not su
pport the notion of an osteoinductive potency of fibrin sealant per se
; however, it is clear that fibrin sealant does not impair bone matrix
gelatin-dependent osteoinduction.